
### [NCIT:C40072](http://purl.obolibrary.org/obo/NCIT_C40072)
**Label:** Benign Ovarian Endometrioid Tumor

**Subclasses:** [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma), 

**Class expressions from DL-Learner:**

- Thing 53.58%
- [NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell) 52.50%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 37.86%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37015](http://purl.obolibrary.org/obo/NCIT_C37015) (Anaplastic Large B-Lymphocyte))) 37.86%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37014](http://purl.obolibrary.org/obo/NCIT_C37014) (Neoplastic Centroblast))) 37.86%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37012](http://purl.obolibrary.org/obo/NCIT_C37012) (Neoplastic T-Immunoblast))) 37.86%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast))) 37.86%


